Templeton International Insights ETF

Alibaba-W Receives Net Inflow from Southbound Stock Connect for 5 Consecutive Days

Benoy Announces Completion of Wuhan Alibaba Center

TSMC Board Approves Dividend Distribution, Employee Bonuses, and a Large-Scale Capital Budget

TSMC leads Taiwan patent applications for the tenth consecutive year in 2025

AstraZeneca's Durvalumab Receives NICE Support for Muscle-Invasive Bladder Cancer Treatment

Qianwen App's Spring Festival 3 billion yuan giveaway campaign sparks consumption boom

TSMC's US-listed shares rise in pre-market trading, boosted by record revenue news

TSMC Approves Up to $3 Billion Investment in Subsidiary TSMC Global

TSMC's Board of Directors Approves NT$206.1 Billion in Employee Performance Bonuses and Compensation for 2025, a New Record High

Alibaba launches AI-powered interactive installation 'Wonder on Ice' for Milan Winter Olympics

Alibaba Cloud Passes ICANN Comprehensive Technical Test Becoming China’s First Full-Chain Top-Level Domain Service Provider

AstraZeneca May Shift to a More Restricted Rebate Model

TSMC Approves Issuance of Up to 60 Billion New Taiwan Dollars of Unsecured Corporate Bonds

TSMC Board Approves $44.962 Billion for Advanced Technology Capacity Upgrades

AstraZeneca CEO Praises US-UK Drug Price Agreement But Finds It Inadequate

Hungarian government launches investigation into Alibaba's surcharge

TSMC's Q3 2025 Dividend Ex-Date is March 17, 2026

Alibaba's Hong Kong stock exhibits a "Death Cross" technical pattern

AstraZeneca's Revenue Grew by 8% to $58.739 Billion in 2025

Alibaba is rumored to have launched an internal project codenamed 'O Plan', possibly related to the Baidu App

Quince Therapeutics

NUVEEN REAL ASSET INM AND GROWTH FD COM USD0.01 S/R 09/03/2026

Jiuzi

Evommune

TuHURA Biosciences

Founder

Nektar Therap

ZW Data Action Tech

SRX Health Solutions

BiomX

Farm Credit Canada has secured C$5 billion in commitments from over 20 private-equity firms and the Royal Bank of Canada to enhance its lending capacity. This funding aims to foster innovation in Canadian agriculture and agri-food sectors, promoting long-term growth and competitiveness. The lender currently manages a C$55 billion loan portfolio and plans to expand its investment strategy by attracting external capital.

MorningStar

Canadian Imperial Bank Comm

ROYAL BANK OF CANADA

Farm Credit Canada Raises C$5 Billion From Private Firms to Expand Lending Capacity

AZNH

AstraZeneca PLC (NASDAQ:AZN) announced a dividend of $1.595 per share, payable on March 23rd to shareholders of record on February 20th. The ex-dividend date is also February 20th. The company has a dividend payout ratio of 39.7%, indicating earnings sufficiently cover the dividend. AstraZeneca's stock rose 3.0% to $193.61, with a market cap of $300.27 billion. Analysts expect earnings of $5.00 per share next year, supporting the dividend. Despite missing Q4 EPS and sales estimates, AstraZeneca forecasts mid-to-high single-digit revenue growth through 2026.

Market Beat

SPDR S&P Biotech

AstraZeneca PLC ADRhedged

AstraZeneca

VanEck Biotech ETF

VG Health

iShares Global Healthcare

ALPS Medical Breakthrough

iShares Biotechnology ETF

First Trust NYSE Arca Biotech Index Fd

Ark Genomic Revolution ETF

Proshares Ultra Nasdaq Biotech

Health Care Select Sector SPDR

Invesco Biotechnology & Genome ETF

iShares US Pharma

AstraZeneca PLC (NASDAQ:AZN) Announces Dividend of 1.60

On Tuesday morning, AstraZeneca's stock experienced a moderate increase due to stronger-than-anticipated sales and profits in the fourth quarter. The company reconfirmed its long-term outlook, projecting a revenue of $80 billion by 2030, prior to an anticipated period of significant growth in 2026.

Unusual Whales

AstraZeneca expects $80 billion revenue by 2030, with rising stock post Q4 earnings beat.

TSMU

TSMX

SOXX

TSMG

Taiwan Semiconductor Manufacturing, a leading chip foundry, announced robust sales growth figures in January. As a result, TSM stock reached an all-time high, signifying a positive market response. The company's performance reflects a significant increase in demand for its products. This achievement further solidifies TSM's position as a key player in the semiconductor industry. The news of the record high stock price demonstrates investor confidence in the company's trajectory.

Taiwan Semiconductor

GraniteShares 2x Long TSM Daily ETF

Direxion Daily TSM Bull 2X Shares

SPDR S&P Semicon

VanEck Semiconductor ETF

iShares Semiconductor ETF

Leverage Shares 2X Long TSM Daily ETF

TSMC stock soars on strong sales, hitting record high after chip foundry reports January sales growth.

HUKX

L100

STAN

On February 10, the UK's FTSE 100 index fell, primarily due to a 4.1% drop in Standard Chartered's shares following the CFO's departure. BP also saw a 4% decline after suspending its share buyback program. Political turmoil surrounding Prime Minister Keir Starmer added to market pressures. Despite Barclays reporting a 12% profit increase, its shares dipped 1.6%. AstraZeneca gained 0.3% on positive growth forecasts. The British pound and government bond yields stabilized after recent declines.

Talkmarkets

BP PLC-Spons

HSBC FTSE 100 UCITS ETF

Lyxor FTSE 100 UCITS ETF

Standard Chartered PLC

AstraZeneca PLC

The FTSE 100 Finish Line - Tuesday, Feb. 10

CRDO

.DJI

CRDU

Today, the Dow Jones index saw an increase despite a dip in retail sales data. TSMC stock reached a peak during trading. The market coverage highlighted the Dow's surge to a high and Credo's significant growth following an updated outlook.

Credo Tech

Dow Jones Industrial Average

Tradr 2X Long CRDO Daily ETF

iShares Dow Jones US

Guggenheim DJIA Ave Div

SPDR Djia

Dow Jones index rises despite weak retail sales, TSMC stock hits high, Credo explodes on updated outlook.

National Bank Says March-April More Problematic Than February for Canada Provincial Bonds

marketscreener

National Bank Says March-April More Problematic Than February for Canada Provincial Bonds

AstraZeneca reported Q4 2025 sales of $15.50 billion, a 4% increase YoY, with adjusted EPS of $2.12. The cancer segment contributed 45% of sales, growing 11% to $7.03 billion. Key drugs like Tagrisso and Imfinzi saw significant sales increases. U.S. sales rose 6% to $6.93 billion. For FY 2026, AstraZeneca anticipates mid-to-high single-digit revenue growth and low double-digit EPS growth. Shares rose 2.82% to $193.31, nearing a 52-week high.

benzinga_article

AstraZeneca Cancer Portfolio Dominates Sales With Massive Double Digit Growth

Nvidia shares fell about 1% despite strong demand for AI chips, as investor concerns over potential semiconductor tariffs eased. The stock remains near its yearly high, buoyed by positive signals from Taiwan Semiconductor Manufacturing (TSMC), which reported a 37% revenue increase. OpenAI's monthly growth of over 10% in processor demand also supports optimism. Potential tariff relief for U.S. tech firms linked to TSMC's $165 billion investment in U.S. manufacturing could further benefit Nvidia. Meanwhile, AMD and Broadcom saw slight gains in the sector.

- Nvidia shares fell by 1% as investor worries about potential tariffs on imported semiconductors diminished.  
- The stock remains close to its highest level this year, bolstered by strong demand for AI chips and positive revenue reports from Taiwan Semiconductor Manufacturing.  
- Competitors like AMD and Broadcom also saw slight gains, while Nvidia may benefit from possible tariff exemptions related to TSMC's substantial investment in U.S. manufacturing.

GuruFocus

GraniteShares 2x Long AMD Daily ETF

T-Rex 2X Inverse NVIDIA Daily Target ETF

Invesco AI and Next Gen Software ETF

Direxion Daily AVGO Bull 2X Shares

Defiance Daily Target 2X Long AVGO ETF

Leverage Shares 2X Long AVGO Daily ETF

Roundhill AVGO WeeklyPay ETF

Direxion Daily NVDA Bull 2X Shares

AXS 1.5X NVDA Bear Daily ETF

GraniteShares 2x Long AVGO Daily ETF

Direxion Daily NVDA Bear 1X ETF

Invesco S&P 500 Equal Weight Tech ETF

NVIDIA

GraniteShares 2x Long NVDA Daily ETF

Direxion Daily AMD Bull 2X Shares

YieldMax NVDA Option Income Strategy ETF

Invesco PHLX Semiconductor ETF

VG Info Tech

ISHRS S&P Glb It

Invesco Semiconductors ETF

GraniteShares 2x Short NVDA Daily ETF

T-Rex 2X Long NVIDIA Daily Target ETF

Broadcom

Nvidia Shares Slide Despite Strong AI Chip Demand

RBC Previews Canadian Banks' Fiscal First-Quarter Results

Toronto Dominion Bank

Bank of Montreal

Bank of Nova Scottia

RBC Previews Canadian Banks' Fiscal First-Quarter Results

SOXL

Taiwan Semiconductor Manufacturing Co (TSMC) has approved a US$44.96 billion capital budget to enhance its technology capacity and support new fabrication plants amid rising global demand, particularly for AI applications. The board also announced a record NT$206.15 billion in employee bonuses and profit-sharing for last year, reflecting increased profitability. TSMC reported a consolidated revenue of NT$3.81 trillion and net income of NT$1.72 trillion for the year. Additionally, a cash dividend of NT$6.0 per share was approved for the fourth quarter, with strong sales driven by demand for advanced 3-nanometer chips.

- Taiwan Semiconductor Manufacturing Co. (TSMC) approved a US$44.96 billion capital budget to enhance advanced technology capacity and fund fab construction.  
- The budget aims to support rising global demand, including an upgrade to its Kumamoto facility for 3-nanometer chip production amidst an AI boom.  
- TSMC reported record financial performance, with consolidated revenue of NT$3.81 trillion and net income of NT$1.72 trillion, alongside increased employee bonuses reflecting its profitability.

Taipei Times

Direxion Semicon Bull 3X

TSMC approves US$44.96 billion budget amid AI boom

TSMZ

The Ministry of Economic Affairs has initiated the construction of a NT$3.772 billion semiconductor R&D base in Hsinchu County, part of the Chip-based Industrial Innovation Program. This facility will support small and medium-sized firms by providing pilot verification for IC designs and advanced manufacturing processes. Expected to be operational by 2028, it aims to enhance Taiwan's competitiveness in the global semiconductor industry, particularly in AI and quantum technologies. The project is supported by key industry players, including Taiwan Semiconductor Manufacturing Co.

- The Ministry of Economic Affairs has initiated the construction of an advanced semiconductor research and development base in Jhudong Township, with an investment of NT$3.772 billion (US$119.56 million).  
- This project aims to support small and medium-sized firms in semiconductor industries by providing pilot verification services and advanced manufacturing processes, expected to shorten product development time by 30%.  
- It will enhance Taiwan's competitiveness in the global semiconductor market by facilitating cutting-edge technology development and supporting local innovation amid evolving global supply chains.

Direxion Daily TSM Bear 1X Shares

Ground broken on chip R&D base

Spotify posts significant gains in monthly active users, while CVS trades higher after earnings.

Coca-Cola Europacific Partners

Spotify

Upwork

Coca Cola

S&P Global

Coca-Cola Bottling

CVS Health

iShares US Consumer Staples ETF

SPDR S&P Software

Invesco Food & Beverage ETF

First Trust NASDAQ Food & Beverage

Tradr 2X Long DDOG Daily ETF

iShares Expanded Tech Software Sector ETF

SPDR FD Consumer Staples

Proshares Big Data Refiners ETF

VG S&P 500

VG Consumer Stap

iShares Core S&P 500

SPDR S&P 500

These stocks are today’s movers: Spotify, S&P Global, CVS, Coca-Cola, TSMC, Datadog, Upwork, Credo, and more

00700

09988

517770

513770

512380

516190

516620

Geopolitical tensions are driving investors to diversify, leading to an analysis of three China-focused ETFs: KWEB, ISVBF, and XTTRF. KWEB, targeting China's internet sector, offers a 6.1% yield with a strong buy consensus and a 28.6% upside potential. It includes major companies like Alibaba and Tencent. This comparison helps investors choose the best ETF for a diversified portfolio amid trade war risks.

- Geopolitical tensions are driving investors to diversify globally, leading to the analysis of three China-focused ETFs: KWEB, ISVBF, and XTTRF.  
- KWEB targets China's internet sector and offers regular dividends while holding major stocks like Alibaba and Tencent, with a consensus rating of Strong Buy and an average price target suggesting significant upside.  
- This comparison aids investors in selecting the most suitable ETF for their diversified portfolios amid market volatility.

Tip Ranks

TENCENT

BABA-W

AXA SPDB CSI Hugangshen Game and Culture Media ETF

Hwabao CSI HK Equities Internet ETF

Yinhua MSCI China A ETF

ChinaAMC CSI Cultural Entertainment Media ETF

Guotai CSI Movies Theme ETF

KWEB vs. ISVBF vs. XTTRF: Which Is the Best China ETF amid Trade War Risks?

Wesbanco Bank Inc. increased its stake in AstraZeneca PLC by 4.4% in Q3, owning 129,040 shares valued at $9.9 million. Other institutional investors also raised their holdings, with Primecap Management Co. owning over 41 million shares. AstraZeneca's stock opened at $188.40, with a market cap of $292.19 billion. Analysts have mixed ratings, with ten recommending a buy and one a sell, reflecting a consensus rating of "Moderate Buy."

AstraZeneca PLC $AZN Shares Purchased by Wesbanco Bank Inc.

Templeton International Insights ETF(TINS.US)

Farm Credit Canada Raises C$5 Billion From Private Firms to Expand Lending Capacity

AstraZeneca PLC (NASDAQ:AZN) Announces Dividend of 1.60

AstraZeneca expects $80 billion revenue by 2030, with rising stock post Q4 earnings beat.

TSMC stock soars on strong sales, hitting record high after chip foundry reports January sales growth.

The FTSE 100 Finish Line - Tuesday, Feb. 10